Publication

Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis

Liver International 41(8):1853-1866, 2021

Perakakis N, Stefanakis K, Feigh M, Veidal SS, Mantzoros CS

Share this page

Resource Library

Related resources

Healthy liver from an adult mouse

Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH

The selective peroxisome proliferator‐activated receptor gamma modulator CHS‐131 improves liver histopathology and metabolism in a mouse model of obesity and nonalcoholic steatohepatitis

Metabolic, biochemical and histological effects of semaglutide in a CDAA-HFD-induced non-obese and biopsy-confirmed rat model of NASH with progressive fibrosis and tumor development

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650